+ Pharmaceuticals
Patient Daily | Mar 4, 2026

Teva secures $400M investment from Blackstone for inflammatory bowel disease drug

Teva has announced a $400 million funding agreement with Blackstone Life Sciences to support the development of duvakitug, a monoclonal antibody being developed in partnership with Sanofi for inflammatory bowel diseases.

Trending News

Current News

More News

See all
FTC

FTC Challenges Medical Device Coatings Deal

From Federal Trade Commission | Mar 6, 2025

Fierce Healthcare

Winners and losers in healthcare after averted shutdown

From Fiercehealthcare | Jan 23, 2025

 American Medical Association

Bipartisan bill would stabilize Medicare physician pay for 2025

From American Medical Association | Oct 30, 2024

FDA

$76 Million in Illegal E-Cigarettes Seized in Joint Federal Operation

From U.S. Food And Drug Administration (fda) | Oct 22, 2024